The global sleep apnea oral appliances market is projected to reach USD 0.7 billion by 2027 from USD 0.3 billion in 2022, at a CAGR of 15.2% during the forecast period. The sleep apnea oral appliances market is driven by large pool of undiagnosed sleep apnea patients, and growing awareness of the effects of untreated sleep apnea.

The top players in this market are SomnoMed (Australia), ResMed (US), Whole You, Inc. (US), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US). These players lead the market because of their extensive product portfolios offering sleep apnea oral appliances. These players have also invested in organic strategies such as product launches and regulatory approvals and inorganic growth strategies such as partnerships, collaborations, acquisitions, and agreements to maintain their market shares.